Antibiotic Targets, Resistance Mechanisms, Cell Morphology, and Immune Disorders in Microbiology

Antibiotic Targets and Resistance Mechanisms

Overview of Antibiotics

Antibiotics are antimicrobial agents produced by microorganisms, mainly certain bacteria and fungi. They function by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic), targeting essential molecular processes within the cell.

• Definition: Antibiotics are natural or synthetic compounds that inhibit or kill microorganisms, especially bacteria.

• Applications: Used in medicine to treat bacterial infections, in agriculture, and as research tools.

Major Molecular Targets of Antibiotics

• DNA Replication, RNA Synthesis, and Protein Synthesis: Many antibiotics inhibit enzymes involved in these processes, halting cell growth and division.

• Transcription Inhibition: Prevents mRNA synthesis, thereby stopping new protein production.

• Protein Synthesis Inhibition: Targets ribosomal subunits, blocking translation.

Antibiotics Targeting Cell Membrane and Cell Wall

• Cell Membrane Disruption: Some antibiotics disrupt the structure of the gram-negative outer membrane, causing leakage and cell death.

• Cell Wall Synthesis Inhibition: β-lactam antibiotics (e.g., penicillins, cephalosporins) inhibit peptidoglycan synthesis by blocking transpeptidation, leading to cell lysis.

• Metabolic Process Inhibition: Some antibiotics target specific metabolic reactions essential for bacterial survival.

Mechanisms of Antibiotic Resistance

Bacteria can survive antibiotic exposure through genetically encoded resistance mechanisms, which fall into four main classes:

• 1. Modification of the Drug Target: Mutations alter the antibiotic's binding site, reducing efficacy.

• 2. Enzymatic Inactivation: Bacterial enzymes chemically modify or degrade the antibiotic.

• 3. Efflux Pumps: Proteins actively export antibiotics out of the cell, lowering intracellular concentrations.

• 4. Metabolic Bypasses: Bacteria use alternative metabolic pathways to circumvent the antibiotic's effect.

Resistance can arise from spontaneous chromosomal mutations or acquisition of resistance genes via mobile genetic elements (e.g., R plasmids), often transferred by horizontal gene flow.

Efflux Pumps and Biofilm-Associated Resistance

• Efflux Pumps: Common in gram-negative bacteria, these transporters can expel multiple antibiotic classes, contributing to multidrug resistance.

• Biofilms: Bacterial growth in biofilms increases resistance, making infections harder to treat.

Persistence and Dormancy

Besides resistance, some bacteria exhibit persistence, where a subpopulation transiently tolerates antibiotics by entering a dormant state. These persister cells are genetically identical to susceptible cells but survive due to metabolic inactivity.

• Mechanism: Dormancy prevents antibiotics from targeting active processes. After treatment, persisters can resume growth.

• Clinical Relevance: Persisters contribute to infection recurrence after apparent treatment success.

Toxin–Antitoxin (TA) Modules and Stringent Response

• TA Modules: Encode a toxin that inhibits growth and an antitoxin that neutralizes the toxin. Found in many bacteria and archaea.

• Stringent Response: Triggered by ribosome stalling, leading to reduced rRNA/tRNA synthesis, slowed DNA replication, and entry into dormancy.

• Phenotypic Heterogeneity: Random differences in gene expression cause only a subset of cells to become persisters.

Determinants of Cell Morphology

The Bacterial Cytoskeleton and Cell Shape

The cytoskeleton provides structural support and determines the shape of bacterial cells, such as spheres, rods, and spirals. Key proteins involved include SEDS proteins and MreB.

• SEDS Proteins: Involved in shape, elongation, division, and sporulation; homologous to eukaryotic cytoskeletal proteins.

• MreB: Major shape-determining protein in bacteria, forming filaments beneath the cytoplasmic membrane and recruiting proteins for cell wall synthesis (e.g., RodA).

• Elongasome: Protein complex involved in cell wall elongation; inactivation of MreB or elongasome proteins causes rod-shaped bacteria to become cocci.

Immune Disorders: Allergy, Hypersensitivity, and Autoimmunity

Types of Hypersensitivity

Hypersensitivity reactions are inappropriate or exaggerated immune responses. They are classified as antibody-mediated (immediate, Type I) or cell-mediated (delayed-type, Type IV).

• Type I (Immediate) Hypersensitivity: Also called allergy; involves IgE-coated mast cells releasing vasoactive substances (e.g., histamine, serotonin) upon allergen exposure. Symptoms range from mild (rash, sneezing) to severe (anaphylaxis).

• Type IV (Delayed-Type) Hypersensitivity (DTH): Cell-mediated response causing tissue damage hours after antigen exposure, peaking at 24–48 hours. Commonly associated with skin reactions and certain autoimmune conditions.

Mechanisms and Clinical Features

• Immediate Hypersensitivity: Rapid onset; treated with epinephrine (for anaphylaxis) or antihistamines/steroids (for milder symptoms).

• Delayed-Type Hypersensitivity: Involves T cells and cytokine-mediated inflammation; used diagnostically (e.g., tuberculin skin test).

Autoimmunity

Autoimmune diseases result from immune responses against self antigens, due to failure in eliminating self-reactive T or B cells.

• Cell-Mediated Autoimmunity: T cells attack self tissues, causing organ dysfunction.

• Autoantibody-Mediated (Type II) Autoimmunity: Autoantibodies bind to self antigens, activating complement and causing cell destruction.

• Immune Complex–Mediated (Type III) Autoimmunity: Autoantibodies form complexes with soluble self antigens, depositing in tissues and triggering inflammation.

Treatment: Organ-specific diseases may be easier to treat. Monoclonal antibodies and immunosuppressive drugs are used. Genetic factors (e.g., MHC proteins) influence susceptibility.

Antimicrobial Drug Resistance and New Treatment Strategies

Mechanisms of Antimicrobial Drug Resistance

Resistance is the acquired ability of microbes to withstand antimicrobial agents. Resistance genes are often located on R plasmids, which can be horizontally transferred.

• Mechanisms: Drug modification/inactivation, prevention of uptake, and efflux pumps.

• Spread: Overuse of antibiotics in medicine and agriculture accelerates resistance.

• Prevention: Use antibiotics only for susceptible pathogens, at adequate doses and durations.

New Drugs and Strategies

• Novel Compounds: New drugs must target unique sites or have novel structures to avoid existing resistance.

• Combination Therapy: Using multiple drugs reduces the likelihood of resistance but can be thwarted by multidrug-resistant plasmids.

• Targeting Unexploited Pathways: Example: Platensimycin disrupts bacterial lipid biosynthesis.

• Resistance Inhibitors: Compounds that block resistance mechanisms can preserve antibiotic efficacy.

Major Antibiotic Targets in Bacteria

• Cell Wall: β-lactam antibiotics (penicillins, cephalosporins) inhibit transpeptidation in peptidoglycan synthesis. Highly selective for bacteria.

• Protein Synthesis: Aminoglycosides and tetracyclines target the 30S ribosomal subunit; macrolides target the 50S subunit.

• Nucleic Acid Synthesis: Quinolones inhibit DNA gyrase; other drugs inhibit RNA synthesis.

• Metabolic Pathways: Growth factor analogs (e.g., sulfa drugs) mimic essential nutrients, disrupting metabolism.

Table: Mechanisms of Antibiotic Resistance

Mechanism	Description	Example
Modification of Drug Target	Mutation alters antibiotic binding site	Altered RNA polymerase (rifampin resistance)
Enzymatic Inactivation	Enzymes degrade or modify antibiotic	β-lactamase inactivates penicillins
Efflux Pumps	Transporters expel antibiotics from cell	Multidrug efflux pumps in Gram-negatives
Metabolic Bypass	Alternative pathways circumvent antibiotic effect	Alternate folic acid synthesis in sulfa resistance

Table: Major Antibiotic Classes and Their Targets

Antibiotic Class	Target	Example	Notes
β-lactams	Cell wall synthesis (transpeptidation)	Penicillin, Cephalosporin	Highly selective for bacteria
Aminoglycosides	30S ribosomal subunit	Streptomycin	Inhibits translation
Tetracyclines	30S ribosomal subunit	Tetracycline	Broad-spectrum
Macrolides	50S ribosomal subunit	Erythromycin	Inhibits translation
Quinolones	DNA gyrase	Ciprofloxacin	Blocks DNA supercoiling
Sulfonamides	Folic acid synthesis	Sulfa drugs	Growth factor analogs

Key Equations and Concepts

• Transpeptidation Reaction (Cell Wall Synthesis):

$\text{Peptidoglycan cross-linking:} \\ \text{Peptide}_1-\text{Glycan} + \text{Peptide}_2-\text{Glycan} \xrightarrow{\text{Transpeptidase}} \text{Cross-linked Peptidoglycan}$

• Antibiotic Selection Pressure: The use of antibiotics selects for resistant mutants, increasing their prevalence in microbial populations.

Additional info:

• Some content on the stringent response and TA modules was expanded for clarity.

• Tables were inferred and constructed based on standard microbiology knowledge.